Share on Facebook Share on Twitter Email
Answers.com

Menstrual cycle

 
Sci-Tech Dictionary: menstrual cycle
(′men·strə·wəl ′sī·kəl)

(physiology) The periodic series of changes associated with menstruation and the intermenstrual cycle; menstrual bleeding indicates onset of the cycle.


Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
World of the Body: menstrual cycle
Top

Throughout a woman's reproductive life — from puberty to the menopause — the ovaries are programmed to produce a mature egg (ovum) approximately every 28 days and to prepare the uterus (womb) for implantation of an embryo if the egg becomes fertilized. To achieve this reproductive competence the ovaries must receive the correct hormonal signals from the brain and the pituitary gland. These signals stimulate the production of female sex hormones and the cyclical changes which occur in the ovary during each normal menstrual cycle. In turn the sex steroids released by the ovary induce changes in the lining of the womb and other parts of the female reproductive tract. The system is subtly regulated and fine-tuned by feedback effects of the ovarian steroid hormones on hormone secretions from the hypothalamus and pituitary gland, so there is a complex interplay of hormones and feedback signals which ultimately controls female fertility. Collectively these events constitute the menstrual cycle.

The first day of the menstrual cycle is defined as the first day of menstrual blood loss. This is when the uterus begins to shed its lining and bleeding occurs. At this time the secretion of hormones (oestrogen and progesterone) from the ovaries is at a minimum. This diminishes the braking effect that circulating ovarian hormones have on the secretion of the gonadotrophic hormones from the pituitary gland, namely luteinizing hormone (LH) amd follicle stimulating hormone (FSH). As a consequence these pituitary secretions increase and stimulate a new wave of activity in the ovaries.

Early in the cycle, FSH stimulates growth of a few follicles (egg-containing ‘sacs’) in each ovary. By about day 10 the ovaries contain several follicles with a diameter of 14-21 mm. As mid cycle approaches, all but one of these degenerate, and only the ‘dominant’ follicle becomes fully mature, with a diameter of 20-25 mm. What determines which follicle becomes the dominant one, and in which ovary, remains speculative. Local hormones or other factors acting within the ovaries may play an important role. This first half of the ovarian cycle is known as the follicular phase and is characterized by increasing secretions of oestrogen from the developing follicles; this is released into the bloodstream, reaches the uterus, and causes its lining to thicken: the glands enlarge and it becomes richly supplied with blood vessels: the proliferative phase of the uterine cycle.

In most normal human menstrual cycles only one follicle reaches full maturity, to be released at ovulation, on about day 14. The occasional release of two accounts for non-identical twins, and fertility drugs can increase the number of follicles reaching maturity at mid cycle. These drugs are either pituitary gonadotrophins, or synthetic chemicals which interfere with the negative feedback loop in such a way as to promote an increase in the release of these hormones from the pituitary gland itself. In both cases the ovaries receive an increased ‘drive’ for follicular development, and thus several follicles will mature. Such drugs are used for treating certain types of infertility, and are given to women undergoing in vitro fertilization (IVF) treatment. If the result is multiple ovulation, the chances of fertilization are increased or, in the case of IVF, more than one mature egg can be recovered for external fertilization and subsequent implantation.

At mid cycle there is a dramatic change of events. There is a high blood concentration of oestrogen, but this ceases to have a braking (negative feedback) effect on the pituitary hormones. About 24-48 hours after the peak of oestrogen production a surge of the gonadotrophins occurs — especially of luteinizing hormone. This is one of the rare biological examples of a positive feedback action. The surge causes the mature ‘dominant’ follicle to rupture and release its egg within 9-12 hours. Indeed, one way of predicting ovulation is by the detection of the increase in luteinizing hormone in the blood, which is reflected in the urine. This is the scientific basis for the kits which are commercially available to identify the most likely time for conception.

Changes of hormone concentrations in the blood during a 28-day menstrual cycle, and the associated changes in follicular development and ovulation (follicular phase), formation and degeneration of the corpus luteum (luteal phase), cyclical growth and degeneration of the endometrium of the womb, and changes in basal body temperature
Changes of hormone concentrations in the blood during a 28-day menstrual cycle, and the associated changes in follicular development and ovulation (follicular phase), formation and degeneration of the corpus luteum (luteal phase), cyclical growth and degeneration of the endometrium of the womb, and changes in basal body temperature



At the time of ovulation there is a small rise in body temperature. This is thought to be due to the action of rising progesterone in the blood, resetting in some way the ‘thermostat’ in the brain which controls our body temperature. This small rise can be used to indicate when ovulation occurs, but obtaining reliable temperature measurements is difficult, making the method often unsatisfactory. Some women feel mild pain in the abdomen around the time of ovulation, lasting from a few minutes to a couple of hours. Known as Mittelschmerz (German for ‘midpain’), it is probably caused by irritation of the abdominal wall due to blood and fluid escaping from the ruptured follicle. Changes in the cervical mucus also occur about the time of ovulation.

After ovulation the empty follicle left behind in the ovary is remodelled, and it plays an important role in the second half of the menstrual cycle, known as the luteal phase of the ovarian cycle. The cells remaining in the ruptured follicle proliferate rapidly and form the corpus luteum. This ‘yellow body’ produces increasing amounts of progesterone and some oestrogen, and these hormones act on the lining of the womb — it becomes thick and spongy and its glands secrete nutrients that can be used by the embryo if fertilization has occurred: this is the secretory phase of the uterine cycle. The high progesterone level in the blood, together with oestrogen, also exerts negative feedback effects, which decrease the secretion of the gonadotrophin-promoting secretion by which the hypothalamus influences the pituitary. Small amounts of gonadotrophins nevertheless continue to maintain the function of the corpus luteum — but if fertilization does not occur, towards the end of the cycle this support fails and the corpus luteum breaks down. The precise mechanisms which induce this degeneration are unknown, but the consequences are that progesterone and oestrogen secretions decline, the hormonal support of the uterine lining is lost, the spiral arteries contract, and the lining cells, starved of their blood supply, break away. Menstrual bleeding ensues. A new cycle begins.

While the average time for each menstrual cycle is typically depicted as 28 days, cycles do vary considerably in length, ranging from 25 days to 35 days. It is usually the length of the first (follicular) phase of the cycle that accounts for most of the variation. The luteal phase is more likely to last the typical 14 days, with ovulation occurring two weeks before rather than after the onset of menstruation, so it is unpredictable. Furthermore, the luteal phase in some women can also vary. This variability clearly makes ‘safe period’ birth control unreliable.

— Saffron Whitehead

Bibliography

  • Jones, R. E. (1997). Human reproductive biology, (2nd edn). Academic Press, New York

See also menstruation; premenstrual tension; ova; ovary; sex hormones; uterus.

Dental Dictionary: menstrual cycle
Top

n

A recurring cycle of change in the endometrium during which the decidual layer of the endometrium is shed, then regrows, proliferates, is maintained for several days, and is shed again at menstruation. The average length of the cycle is 28 days.

Encyclopedia of Public Health: Menstrual Cycle
Top

The menstrual cycle encompasses approximately four weeks framed by two menstrual flows (called "periods"). Though few population-based, hormonally valid prospective studies of menstrual cycle intervals and ovulation are available, normal menstrual cycles are twenty-one to thirty-five days long with flow lasting three to five days. The menstrual cycle occurs during approximately thirty to forty-five years of a woman's life beginning with menarche (the first flow) at ages ten to sixteen. The menstrual cycles permanently end with menopause (one year following the final menstrual period), which occurs between ages forty and fifty-eight.

Within each normal menstrual cycle a complex, highly coordinated series of hormonal, physiological and physical changes occur in a predictable fashion. The cycle is divided by ovulation into two phases called follicular and the luteal phase. The start of flow is cycle day 1. The follicular phase leads to increased sexual interest at midcycle, slippery (like egg white) cervical mucous, and release of an egg (ovulation). Ovulation marks the end of the follicular and start of the luteal phase that itself ends with flow. Luteal phase length is ten to sixteen days, during which changes occur in the endometrium (lining of the uterus), breasts, fluid balance, exercise physiology, metabolism, and women's experiences (molimina). If fertilization does not occur, the thickened endometrium starts to shed and a new cycle begins. The normal menstrual flow entails approximately 43 ± 2.3 (median 32) milliliters of blood loss and will soak two to eight regular-sized pads or tampons.

Menstrual interval and ovulatory disturbances (see below) are most common in adolescence (young gynecological age) and in the years prior to menopause (perimenopau). In general, they are reversible and treatable and thus represent disturbances of physiology rather than diseases.

Disturbances of Menstrual Flow

Menorrhagia, abnormally heavy flow, occurs at the extremes of menstrual life when ovulation disturbances are also common. Women older than forty-five or fifty tend to have greater blood loss with more variability than women of other ages. The cause of menorrhagia is often unclear but it entails soaking over eleven to sixteen pads or tampons and is associated with clots, cramping (dysmenorrhea), and anemia.

Disturbances of Cycle Interval

Amenorrhea, no vaginal bleeding for six or more months, indicates a rare anatomical abnormality (of uterus or vagina), very low or noncyclic, normal estrogen production. Primary amenorrhea means delay of menarche beyond fifteen years of age in 6.4 percent of the population.

Secondary amenorrhea, after menarche, is rare—it occurs in about 1 to 2 percent of the population. The most common causes are (undiagnosed) pregnancy, lactation, young gynecological age (years after menarche), undernutrition or weight loss, and emotional stress (including depression, anxiety, and eating disorders [anorexia and bulemia]). Although amenorrhea is attributed to exercise, it is more likely related to coexistent emotional stress, nutritional deficiencies, and young age.

Oligomenorrhea, flow at intervals longer than thirty-six (but less than 180) days, is more common than amenorrhea and also occurs at the extremes of reproductive life. However, 30 percent of women twenty to forty-nine years old had cycle intervals over sixty days. Women reporting a body mass index at age eighteen that was over twenty-four had increasing risks for oligomenorrhea with increasing weight.

Polyemnorrhea, (short cycles) are under twenty-one days in length, are common at extremes of reproductive life, and imply higher estrogen production. Short cycles are commonly abnormal in ovulatory characteristics and often have increased in flow.

Disturbances of Ovulation

Ovulatory disturbances are of two main types: low hypothalamic/pituitary stimulation, called "hypothalamic" or high pituitary stimulation called "anovulatory androgen excess." Ovulatory disturbances of either type include anovulation and cycles with ovulation but short luteal phase length. Anovulation (lack of egg release) universally causes ovarian cysts.

Hypothalamic ovulatory disturbances are common but not often detected because they occur in "regular" cycles of normal interval and flow. Hypothalamic ovulatory disturbances explain approximately 25 percent of infertility and 20 percent of prospectively documented cancellous bone loss. Seventy-five percent of normal weight, healthy premenopausal women experienced at least one cycle with ovulatory disturbance during one-year prospective monitoring, thus this may be an unrecognized cause for osteoporosis. Although not all investigators agree, no other prospective one-year study has simultaneously and continuously documented both ovulation and bone loss.

Hypothalamic ovulatory disturbances are related to cortisol excess caused by physical or psychological stress including cognitive dietary restraint in normal weight women. Ovulatory disturbances may also be associated with menorrhagia and increased risk for anemia, endometrial cancer, breast swelling, nodularity and/or pain (fibrocystic) problems, troublesome premenstrual symptoms, and breast cancer.

Anovulatory androgen excess (commonly called "polycystic ovarian disease") occurs in approximately 5 percent of reproductive-age women. This may cause cycle or flow disturbances, acne, or unwanted male-pattern hair changes (increased facial and body hair and head hair loss). This type of anovulation may be related to insulin excess/resistance, gynecological age, and heredity. Health outcomes related to prolonged anovulatory androgen excess include increased risks of endometrial and breast cancers and probable cardiovascular disease (abnormal lipids, central obesity, increased waist/hip/ratio, and insulin resistance) but protection from osteoporosis.

Overview of Menstrual Cycle and Ovulatory Disturbances

Cycle interval and ovulatory disturbances are common in adolescence and perimenopause. The majority are reversible (except in perimenopause). Treatment with cyclic progesterone is physiological and increases bone mineral and thus minimizes osteoporosis. Population-based, prospective studies of menstrual cycles, ovulatory characteristics, and health parameters are needed.

(SEE ALSO: Anorexia; Contraception; Endocrine Disruptors; Fecundity and Fertility; Nutrition; Reproduction; Sports Medicine; Women's Health)

Bibliography

Barr, S. I.; Janelle, K. C.; and Prior, J. C. (1994). "Vegetarian Versus Nonvegetarian Diets, Dietary Restraint, and Subclinical Ovulatory Disturbances: Prospective Six Month Study." American Journal Clinical Nutrition 60:887–894.

Coulam, C. B.; Annegers, J. F; and Kranz, J. S. (1983). "Chronic Anovulation Syndrome and Associated Neoplasia." Obstetrics Gynecology 61:403–407.

Hallberg, L.; Hogdahl, A. M.; Nillson, L.; and Rybo, G. (1966). "Menstrual Blood Loss: A Population Study." Acta Obstetrics and Gynecology Scandinavia. 45:330–351.

Landgren, B. M.; Unden, A. L.; and Diczfalusy, E. (1980). "Hormonal Profile of the Cycle in 68 Normally Menstruating Women." Acta Endocrinology Copenhagen 94:89–98.

Prior, J. C.; Vigna, Y. M.; Schechter, M. T.; and Burgess, A. E. (1990). "Spinal Bone Loss and Ovulatory Disturbances." New England Journal of Medicine 323:1221–1227.

Prior, J. C.; Vigna, Y. M.; Shulzer, M.; Hall, J. E.; and Bonen, A. (1990). "Determination of Luteal Phase Length by Quantitative Basal Temperature Methods: Validation Against the Midcycle LH Peak." Clinical & Investigative Medicine 45:377–392.

Ramcharan, S.; Love, E. J.; Frick, G. H.; and Goldfien, A. (1992). "The Epidemiology of Premenstrual Symptoms in a Population-Based Sample of 2,650 Urban Women: Attributable Risk and Risk Factors." Journal of Clinical Epidemiology 45:377–392.

Rich-Edwards, J. W.; Goldman, M. B.; Willett, W. C.; Hunter, D. J.; Stampfer, M. J.; Colditz, G. A. and Manson, J. E. (1994). "Adolescent Body Mass Index and Infertility Caused by Ovulatory Disorder." American Journal of Obstetrics and Gynecology 171:171–177.

Treloar, A. E.; Boyton, R. E.; Behn, B. G.; and Brown, B. W. (1967). "Variations of the Human Menstrual Cycle through Reproductive Life." International Journal of Fertility 9:77–126.

Vollman, R. F. (1977). Major Problems in Obstetrics and Gynecology, Vol. 7. Toronto: Saunders.

— JERILYNN C. PRIOR



Sports Science and Medicine: menstrual cycle
Top

The cycle of changes associated with ovulation (release of an egg cell from an ovary) in sexually mature, non-pregnant females. It occurs at approximately monthly intervals and is characterized by menses (often called menstruation, the period during which blood is lost from the genital tract), changes in the wall of the uterus, and changes in the breasts. The cycle also often involves considerable variations in body weight, total body water, body temperature, metabolic rate, heart rate, and stroke volume (amount of blood leaving the heart at each contraction). These variations may have dramatic effects on the ability to perform exercise, therefore many female athletes use contraceptive pills containing steroids to control their menstrual cycle so that it does not coincide with important events. However, such pills are not very popular among endurance athletes because they sometimes cause weight increases and reduce maximum oxygen uptake. Regular, intensive exercise can disrupt the menstrual cycle (see athletic amenorrhoea).

Health Dictionary: menstrual cycle
Top
(men-strooh-uhl, men-struhl)

The periodic series of changes in the female reproductive system associated with the preparation of the uterus for pregnancy; the cycle is repeated roughly every twenty-eight days. During the menstrual cycle, an ovum is released from one of the ovaries (the release is called ovulation), and the uterus develops an inner lining enriched with blood to prepare it for the possible implantation of a zygote. If fertilization and implantation do not take place, the lining of the uterus is discharged during menstruation.

Wikipedia: Menstrual cycle
Top
Menstrual cycle


The menstrual cycle is a cycle of physiological changes that occurs in fertile females. Overt menstruation (where there is blood flow from the uterus through the vagina) occurs primarily in humans and close evolutionary relatives such as chimpanzees.[1] Females of other species of placental mammal undergo estrous cycles, in which the endometrium is completely reabsorbed by the animal (covert menstruation) at the end of its reproductive cycle. This article focuses on the human menstrual cycle.

The menstrual cycle, under the control of the endocrine system, is necessary for reproduction. It may be divided into three distinct phases: menstruation, the follicular phase and the luteal phase.[2] Ovulation defines the transition from the follicular phase to the luteal phase. The length of each phase varies from woman to woman and cycle to cycle, though the average menstrual cycle is 28 days.[2] Hormonal contraception interferes with the normal hormonal changes with the aim of preventing reproduction.

Stimulated by gradually increasing amounts of estrogen in the follicular phase, menses slow then stop, and the lining of the uterus thickens. Follicles in the ovary begin developing under the influence of a complex interplay of hormones, and after several days one or occasionally two become dominant (non-dominant follicles atrophy and die). Approximately mid-cycle, 24-36 hours after the Luteinizing Hormone (LH) surges, the dominant follicle releases an ovum, or egg in an event called ovulation. After ovulation, the egg only lives for 24 hours or less without fertilization while the remains of the dominant follicle in the ovary become a corpus luteum; this body has a primary function of producing large amounts of progesterone. Under the influence of progesterone, the endometrium (uterine lining) changes to prepare for potential implantation of an embryo to establish a pregnancy. If implantation does not occur within approximately two weeks, the corpus luteum will involute, causing sharp drops in levels of both progesterone and estrogen. These hormone drops cause the uterus to shed its lining in a process termed menstruation.

In the menstrual cycle, changes occur in the female reproductive system as well as other systems (which lead to breast tenderness or mood changes, for example). A woman's first menstruation is termed menarche, and occurs typically around age 12. The end of a woman's reproductive phase is called the menopause, which commonly occurs somewhere between the ages of 45 and 55.

Contents

Terminology

The menarche is one of the later stages of puberty in girls. The average age of menarche in humans is 12 years, but is normal anywhere between ages 8 and 16. Factors such as heredity, diet and overall health can accelerate or delay menarche.[3] The cessation of menstrual cycles at the end of a woman's reproductive period is termed menopause. The average age of menopause in women is 52 years in industrialised countries such as the UK, with anywhere between 45 and 55 being common. Menopause before age 45 is considered premature in industrialised countries[4]. The age of menopause is largely a result of genetics; however, illnesses, certain surgeries, or medical treatments may cause menopause to occur earlier.[5]

The length of a woman's menstrual cycle will typically vary, with some shorter cycles and some longer cycles. A woman who experiences variations of less than eight days between her longest cycles and shortest cycles is considered to have regular menstrual cycles. It is unusual for a woman to experience cycle length variations of less than four days. Length variation between eight and 20 days is considered moderately irregular. Variation of 21 days or more between a woman's shortest and longest cycle lengths is considered very irregular (see cycle abnormalities).[6]

Phases

The menstrual cycle is divided into several phases. The average length of each phase is shown below:

Name of phase Average start day
assuming a 28-day cycle
Average end day
menstrual phase 1 4
follicular phase (also known as proliferative phase) 5 13
ovulation (not a phase, but an event dividing phases) 14 14
luteal phase (also known as secretory phase) 15 26
ischemic phase (some sources group this with luteal phase) 27 28

Menstruation

Menstruation is also called menstrual bleeding, menses, catamenia or a period. The flow of menses normally serves as a sign that a woman has not become pregnant. (However, this cannot be taken as certainty, as a number of factors can cause bleeding during pregnancy; some factors are specific to early pregnancy, and some can cause heavy flow.)[7][8][9] During the reproductive years, failure to menstruate may provide the first indication to a woman that she may have become pregnant.

Eumenorrhea denotes normal, regular menstruation that lasts for a few days (usually 3 to 5 days, but anywhere from 2 to 7 days is considered normal).[10][11] The average blood loss during menstruation is 35 milliliters with 10–80 ml considered normal.[12] (Because of this blood loss, women are more susceptible to iron deficiency than men are.)[13] An enzyme called plasmin inhibits clotting in the menstrual fluid.[14] Cramping in the abdomen, back, or upper thighs is common during the first few days of menstruation. When menstruation begins, symptoms of premenstrual syndrome (PMS) such as breast tenderness and irritability generally decrease.[11] Many sanitary products are marketed to women for use during their menstruation.

Follicular phase

This phase is also called the proliferative phase because a hormone causes the lining of the uterus to grow, or proliferate, during this time.[2]

Through the influence of a rise in follicle stimulating hormone (FSH) during the first days of the cycle, a few ovarian follicles are stimulated.[2] These follicles, which were present at birth[2] and have been developing for the better part of a year in a process known as folliculogenesis, compete with each other for dominance. Under the influence of several hormones, all but one of these follicles will stop growing, while one dominant follicle in the ovary will continue to maturity. The follicle that reaches maturity is called a tertiary, or Graafian, follicle, and it forms the ovum.[2]

As they mature, the follicles secrete increasing amounts of estradiol, an estrogen. The estrogens initiate the formation of a new layer of endometrium in the uterus, histologically identified as the proliferative endometrium. The estrogen also stimulates crypts in the cervix to produce fertile cervical mucus, which may be noticed by women practicing fertility awareness.[15]

Ovulation

An ovary about to release an egg.
Reference ranges for estradiol and progesterone in the menstrual cycle, expressed in mass and molar concentration. The relative concentrations of estradiol and progesterone differ somewhat between the mass and molar scales because of slightly different molar mass. The scale is logarithmic.
Reference ranges for luteinizing hormone and follicle-stimulating hormone in the menstrual cycle, expressed in international units. The scale is logarithmic.

During the follicular phase, estradiol suppresses production of luteinizing hormone (LH) from the anterior pituitary gland. When the egg has nearly matured, levels of estradiol reach a threshold above which they stimulate production of LH. (These opposite responses of LH to estradiol may be enabled by the presence of two different estrogen receptors in the hypothalamus: estrogen receptor alpha—which is responsible for the negative feedback estradial-LH loop—and estrogen receptor beta—which is responsible for the positive estradiol-LH relationship.)[16] In the average cycle this LH surge starts around cycle day 12 and may last 48 hours.

The release of LH matures the egg and weakens the wall of the follicle in the ovary, causing the fully developed follicle to release its secondary oocyte.[2] The secondary oocyte promptly matures into an ootid and then becomes a mature ovum. The mature ovum has a diameter of about 0.2 mm.[17]

Which of the two ovaries—left or right—ovulates appears essentially random; no known left/right co-ordination exists.[18] Occasionally, both ovaries will release an egg;[18] if both eggs are fertilized, the result is fraternal twins.[19]

After being released from the ovary, the egg is swept into the fallopian tube by the fimbria, which is a fringe of tissue at the end of each fallopian tube. After about a day, an unfertilized egg will disintegrate or dissolve in the fallopian tube.[2]

Fertilization by a spermatozoon, when it occurs, usually takes place in the ampulla, the widest section of the fallopian tubes. A fertilized egg immediately begins the process of embryogenesis, or development. The developing embryo takes about three days to reach the uterus and another three days to implant into the endometrium.[2] It has usually reached the blastocyst stage at the time of implantation.

In some women, ovulation features a characteristic pain called mittelschmerz (German term meaning middle pain).[11] The sudden change in hormones at the time of ovulation sometimes also causes light mid-cycle blood flow.[20]

Luteal phase

The luteal phase is also called the secretory phase. An important role is played by the corpus luteum, the solid body formed in an ovary after the egg has been released from the ovary into the fallopian tube. This body continues to grow for some time after ovulation and produces significant amounts of hormones, particularly progesterone.[2] Progesterone plays a vital role in making the endometrium receptive to implantation of the blastocyst and supportive of the early pregnancy; it also has the side effect of raising the woman's basal body temperature.[21]

After ovulation, the pituitary hormones FSH and LH cause the remaining parts of the dominant follicle to transform into the corpus luteum, which produces progesterone and estrogens. The hormones produced by the corpus luteum also suppress production of the FSH and LH that the corpus luteum needs to maintain itself. Consequently, the level of FSH and LH fall quickly over time, and the corpus luteum subsequently atrophies.[2] Falling levels of progesterone trigger menstruation and the beginning of the next cycle. From the time of ovulation until progesterone withdrawal has caused menstruation to begin, the process typically takes about two weeks, with ten to sixteen days considered normal. For an individual woman, the follicular phase often varies in length from cycle to cycle; by contrast, the length of her luteal phase will be fairly consistent from cycle to cycle.[22]

The loss of the corpus luteum can be prevented by fertilization of the egg; the resulting embryo produces human chorionic gonadotropin (hCG), which is very similar to LH and which can preserve the corpus luteum. Because the hormone is unique to the embryo, most pregnancy tests look for the presence of hCG.[2]

Fertile window

The most fertile period (the time with the highest likelihood of pregnancy resulting from sexual intercourse) covers the time from some 5 days before until 1–2 days after ovulation.[23] In an average 28 day cycle with a 14-day luteal phase, this corresponds to the second and the beginning of the third week. However, few cycles are exactly average. A variety of methods have been developed to help individual women estimate the relatively fertile and the relatively infertile days in the cycle: these systems are called fertility awareness.

Fertility awareness methods that rely on cycle length records alone are called calendar-based methods.[24] Methods that require observation of one or more of the three primary fertility signs (basal body temperature, cervical mucus, and cervical position)[25] are known as symptoms-based methods.[24] Urine test kits are available that detect the LH surge that occurs 24 to 36 hours before ovulation; these are known as ovulation predictor kits (OPKs).[26] Computerized devices that interpret basal body temperatures, urinary test results, or changes in saliva are called fertility monitors.

A woman's fertility is also affected by her age.[27] As a woman's total egg supply is formed in fetal life,[28] to be ovulated decades later, it has been suggested that this long lifetime may make the chromatin of eggs more vulnerable to division problems, breakage, and mutation than the chromatin of sperm, which are produced continuously during a man's reproductive life.

Effect on other systems

Some women with neurological conditions experience increased activity of their conditions at about the same time during each menstrual cycle. Many women with epilepsy have more seizures in a pattern linked to the menstrual cycle; this is called "catamenial epilepsy".[29] Different patterns seem to exist (such as seizures coinciding with the time of menstruation, or coinciding with the time of ovulation), and the frequency with which they occur has not been firmly established. Using one particular definition, one group of scientists found that around one-third of women with intractable partial epilepsy have catamenial epilepsy.[29][30][31] An effect of hormones has been proposed, in which progesterone declines and estrogen increases would trigger seizures.[32] Studies by medical journals have found that women experiencing menses are 1.68 percent more likely to commit suicide.[33]

Mice have been used as an experimental system to investigate possible mechanisms by which levels of sex steroid hormones might regulate nervous system function. During the part of the mouse estrous cycle when progesterone is highest, the level of nerve-cell GABA receptor subtype delta was high. Since these GABA receptors are inhibitory, nerve cells with more delta receptors are less likely to fire than cells with lower numbers of delta receptors. During the part of the mouse estrous cycle when estrogen levels are higher than progesterone levels, the number of delta receptors decrease, increasing nerve cell activity, in turn increasing anxiety and seizure susceptibility.[34]

Estrogen levels may affect thyroid behavior.[35] For example, during the luteal phase (when estrogen levels are lower), the velocity of blood flow in the thyroid is lower than during the follicular phase (when estrogen levels are higher).[36]

Among women living closely together, the onsets of menstruation may tend to synchronize somewhat. This McClintock effect was first described in 1971, and possibly explained by the action of pheromones in 1998.[37] However, subsequent research has called this hypothesis into question.[38]

Cycle abnormalities

Infrequent or irregular ovulation is called oligoovulation.[39] The absence of ovulation is called anovulation. Normal menstrual flow can occur without ovulation preceding it: an anovulatory cycle. In some cycles, follicular development may start but not be completed; nevertheless, estrogens will form and will stimulate the uterine lining. Anovulatory flow resulting from a very thick endometrium caused by prolonged, continued high estrogen levels is called estrogen breakthrough bleeding. Anovulatory bleeding triggered by a sudden drop in estrogen levels is called estrogen withdrawal bleeding.[40] Anovulatory cycles commonly occur prior to menopause (perimenopause) and in women with polycystic ovary syndrome.[41]

Very little flow (less than 10ml) is called hypomenorrhea. Regular cycles with intervals of 21 days or fewer are polymenorrhea; frequent but irregular menstruation is known as metrorrhagia. Sudden heavy flows or amounts in excess of 80 ml are termed menorrhagia.[42] Heavy menstruation that occurs frequently and irregularly is menometrorrhagia. The term for cycles with intervals exceeding 35 days is oligomenorrhea.[43] Amenorrhea refers to more than three[42] to six[43] months without menses (in the absence of pregnancy) during a woman's reproductive years.

Ovulation suppression

Hormonal contraception

Half-used blister pack of a combined oral contraceptive. The white pills are placebos.

While some forms of birth control do not affect the menstrual cycle, hormonal contraceptives work by disrupting it. Progestogen negative feedback decreases the pulse frequency of gonadotropin-releasing hormone (GnRH) release by the hypothalamus, which decreases the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) by the anterior pituitary. Decreased levels of FSH inhibit follicular development, preventing an increase in estradiol levels. Progestogen negative feedback and the lack of estrogen positive feedback on LH release prevent a mid-cycle LH surge. Inhibition of follicular development and the absence of a LH surge prevent ovulation.[44][45][46]

The degree of ovulation suppression in progestogen-only contraceptives depends on the progestogen activity and dose. Low dose progestogen-only contraceptives—traditional progestogen only pills, subdermal implants Norplant and Jadelle, and intrauterine system Mirena—inhibit ovulation in ~50% of cycles and rely mainly on other effects, such as thickening of cervical mucus, for their contraceptive effectiveness.[47] Intermediate dose progestogen-only contraceptives—the progestogen-only pill Cerazette and the subdermal implant Implanon—allow some follicular development but more consistently inhibit ovulation in 97–99% of cycles. The same cervical mucus changes occur as with very low dose progestogens. High dose progestogen-only contraceptives—the injectables Depo-Provera and Noristerat—completely inhibit follicular development and ovulation.[47]

Combined hormonal contraceptives include both an estrogen and a progestogen. Estrogen negative feedback on the anterior pituitary greatly decreases the release of FSH, which makes combined hormonal contraceptives more effective at inhibiting follicular development and preventing ovulation. Estrogen also reduces the incidence of irregular breakthrough bleeding.[44][45][46] Several combined hormonal contraceptives—the pill, NuvaRing, and the contraceptive patch—are usually used in a way that causes regular withdrawal bleeding. In a normal cycle, menstruation occurs when estrogen and progesterone levels drop rapidly.[21] Temporarily discontinuing use of combined hormonal contraceptives (a placebo week, not using patch or ring for a week) has a similar effect of causing the uterine lining to shed. If withdrawal bleeding is not desired, combined hormonal contraceptives may be taken continuously, although this increases the risk of breakthrough bleeding.

Lactational amenorrhea

Breastfeeding causes negative feedback to occur on pulse secretion of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH). Depending on the strength of the negative feedback, breastfeeding women may experience complete suppression of follicular development, follicular development but no ovulation, or normal menstrual cycles may resume.[48] Suppression of ovulation is more likely when suckling occurs more frequently.[6] The production of prolactin in response to suckling is important to maintaining lactational amenorrhea.[49] On average, women who are fully breastfeeding whose infants suckle frequently experience a return of menstruation at fourteen and a half months postpartum. There is a wide range of response between individual breastfeeding women, however, with some experiencing return of menstruation at two months and others remaining amenorrheic for up to 42 months postpartum.[50]

Etymological and biological associations

Nightlighting and the moon

The word "menstruation" is etymologically related to "moon". The terms "menstruation" and "menses" are derived from the Latin mensis (month), which in turn relates to the Greek mene (moon) and to the roots of the English words month and moon—reflecting the fact that the moon also takes close to 28 days to revolve around the Earth (actually 27.32 days). The synodical lunar month, the period between two new moons (or full moons), is 29.53 days long.

Some authors believe women in traditional societies without nightlighting ovulated with the full moon and menstruated with the new moon.[51] A few studies in both humans[52] and animals[53] have found that artificial light at night does influence the menstrual cycle in humans and the estrus cycle in mice (cycles are more regular in the absence of artificial light at night), though none have demonstrated the synchronization of women's menstrual cycles with the lunar cycle. It has also been suggested that bright light exposure in the morning promotes more regular cycles.[54] One author has suggested that sensitivity of women's cycles to nightlighting is caused by nutritional deficiencies of certain vitamins and minerals.[55]

Other animals' menstrual cycles may be greatly different from lunar cycles: while the average cycle length in orangutans is the same as in humans—28 days[56]—the average for chimpanzees is 35 days.[57] Some take this as evidence that the average length of humans' cycle is most likely a coincidence. [58] [59] [60] [61] [62]

Estrus and menstruation

Females of most mammal species advertise fertility to males with visual behavioral cues, pheromones, or both.[63] This period of advertised fertility is known as estrus or heat.[63] In species that experience estrus, females are generally only receptive to copulation while they are in heat[63] (dolphins are an exception).[64] In the estrous cycles of most placental mammals, if no fertilization takes place, the uterus reabsorbs the endometrium. This breakdown of the endometrium without vaginal discharge is sometimes called covert menstruation.[65] Overt menstruation (where there is blood flow from the vagina) occurs primarily in humans and close evolutionary relatives such as chimpanzees.[1] Some species, such as domestic dogs, experience small amounts of vaginal bleeding while in heat; this discharge has a different physiologic cause than menstruation.[66]

A few mammals do not experience obvious, visible signs of fertility (concealed ovulation). In humans, while women can be taught to recognize their own level of fertility (fertility awareness), whether men can detect fertility in women is debated; recent studies have given conflicting results.[67][68] Orangutans also lack visible signs of impending ovulation.[56] Also, it has been said that the extended estrus period of the bonobo (reproductive-age females are in heat for 75% of their menstrual cycle)[69] has a similar effect to the lack of a "heat" in human females.[70]

References

  1. ^ a b Strassmann BI (1996). "The evolution of endometrial cycles and menstruation". Q Rev Biol 71 (2): 181–220. doi:10.1086/419369. PMID 8693059. 
  2. ^ a b c d e f g h i j k l Losos, Jonathan B.; Raven, Peter H.; Johnson, George B.; Singer, Susan R. (2002). Biology. New York: McGraw-Hill. pp. 1207–09. ISBN 0-07-303120-8. 
  3. ^ "At what age does a girl get her first period?," from Menstruation and the Menstrual Cycle, National Women's Health Information Center (accessed June 11, 2005)
  4. ^ "Clinical topic - Menopause". NHS. http://www.cks.nhs.uk/menopause#-292420. Retrieved 2009-11-02. 
  5. ^ Shuman, Tracy (February 2006). "Your Guide to Menopause". WebMD. http://www.webmd.com/content/article/9/2953_504.htm. Retrieved 2006-12-16. 
  6. ^ a b Kippley, John; Sheila Kippley (1996). The Art of Natural Family Planning (4th ed.). Cincinnati, OH: The Couple to Couple League. pp. 92. ISBN 0-926412-13-2. 
  7. ^ Greenfield, Marjorie (2001-09-17). "Subchorionic Hematoma in Early Pregnancy". Ask Our Experts. DrSpock.com. http://www.drspock.com/faq/0,1511,8334,00.html. Retrieved 2008-09-21. 
  8. ^ Anderson-Berry, Ann L; Terence Zach (2007-12-10). "Vanishing Twin Syndrome". Emedicine.com (WebMD). http://www.emedicine.com/med/TOPIC3411.HTM. Retrieved 2008-09-21. 
  9. ^ Ko, Patrick; Young Yoon (2007-08-23). "Placenta Previa". Emedicine.com (WebMD). http://www.emedicine.com/emerg/topic427.htm. Retrieved 2008-09-21. 
  10. ^ The National Women's Health Information Center (November 2002). "What is a typical menstrual period like?". U.S. Department of Health and Human Services. http://www.4woman.gov/faq/menstru.htm#4. Retrieved 2005-06-11. 
  11. ^ a b c John M Goldenring (2007-02-01). "All About Menstruation". WebMD. http://www.webmd.com/a-to-z-guides/all-about-menstruation. Retrieved 2008-10-05. 
  12. ^ David L Healy (2004-11-24). "Menorrhagia Heavy Periods - Current Issues". Monash University. http://www.med.monash.edu.au/ob-gyn/research/menorr.html. 
  13. ^ Harvey LJ, Armah CN, Dainty JR, et al. (October 2005). "Impact of menstrual blood loss and diet on iron deficiency among women in the UK". The British journal of nutrition 94 (4): 557–64. doi:10.1079/BJN20051493. PMID 16197581. http://journals.cambridge.org/abstract_S0007114505002175. Retrieved 2008-10-05. 
  14. ^ Shiraishi M (August 1962). "Studies on identification of menstrual blood stain by fibrin-plate method. I. A study on the incoagulability of menstrual blood". Acta medicinae Okayama 16: 192–200. PMID 13977381. http://escholarship.lib.okayama-u.ac.jp/cgi/viewcontent.cgi?article=3340&context=amo. Retrieved 2008-10-05. 
  15. ^ Weschler, Toni (2002). Taking Charge of Your Fertility (Revised ed.). New York: HarperCollins. pp. 359–361. ISBN 0-06-093764-5. 
  16. ^ Hu L, Gustofson RL, Feng H, et al. (October 2008). "Converse regulatory functions of estrogen receptor-alpha and -beta subtypes expressed in hypothalamic gonadotropin-releasing hormone neurons". Mol. Endocrinol. 22 (10): 2250–9. doi:10.1210/me.2008-0192. PMID 18701637. 
  17. ^ Gray, Henry David (2000). "The Ovum". Anatomy of the human body. Philadelphia: Bartleby.com. ISBN 1-58734-102-6. 
  18. ^ a b Ecochard R, Gougeon A (April 2000). "Side of ovulation and cycle characteristics in normally fertile women". Human reproduction (Oxford, England) 15 (4): 752–5. doi:10.1093/humrep/15.4.752. PMID 10739814. http://humrep.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10739814. 
  19. ^ "Multiple Pregnancy: Twins or More - Topic Overview". WebMD Medical Reference from Healthwise. 2007-07-24. http://www.webmd.com/baby/tc/multiple-pregnancy-twins-or-more-topic-overview. Retrieved 2008-10-05. 
  20. ^ Weschler (2002), p.65
  21. ^ a b Weschler (2002), pp.361-2
  22. ^ Weschler (2002), p.47
  23. ^ Weschler (2002), pp.242,374
  24. ^ a b Medical Eligibility Criteria for Contraceptive Use:Fertility awareness-based methods. Third edition. World Health Organization. 2004. http://www.who.int/reproductive-health/publications/mec/fab.html. Retrieved 2008-04-29. 
  25. ^ Weschler (2002), p.52
  26. ^ MedlinePlus Encyclopedia LH urine test (home test)
  27. ^ Davis, Jeanie Lerche (2004-06-18). "Fertility Treatment Less Successful After 35". WebMD Health News. http://www.webmd.com/infertility-and-reproduction/news/20040618/fertility-treatment-less-successful-after-35. Retrieved 2008-09-21. 
  28. ^ Krock, Lexi (October 2001). "Fertility Throughout Life". 18 Ways to Make a Baby. NOVA Online. http://www.pbs.org/wgbh/nova/baby/fert_text.html. Retrieved 2006-12-24.  Haines, Cynthiac (January 2006). "Your Guide to the Female Reproductive System". The Cleveland Clinic Women's Health Center. WebMD. http://www.webmd.com/content/article/51/40619.htm. Retrieved 2006-12-24. 
  29. ^ a b Herzog AG (March 2008). "Catamenial epilepsy: definition, prevalence pathophysiology and treatment". Seizure : the journal of the British Epilepsy Association 17 (2): 151–9. doi:10.1016/j.seizure.2007.11.014. PMID 18164632. http://linkinghub.elsevier.com/retrieve/pii/S1059-1311(07)00233-6. 
  30. ^ Herzog AG, Harden CL, Liporace J, et al. (September 2004). "Frequency of catamenial seizure exacerbation in women with localization-related epilepsy". Annals of neurology 56 (3): 431–4. doi:10.1002/ana.20214. PMID 15349872. 
  31. ^ Herzog AG, Klein P, Ransil BJ (October 1997). "Three patterns of catamenial epilepsy". Epilepsia 38 (10): 1082–8. doi:10.1111/j.1528-1157.1997.tb01197.x. PMID 9579954. 
  32. ^ Scharfman HE, MacLusky NJ (September 2006). "The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female". Epilepsia 47 (9): 1423–40. doi:10.1111/j.1528-1167.2006.00672.x. PMID 16981857. PMC 1924802. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0013-9580&date=2006&volume=47&issue=9&spage=1423. 
  33. ^ Enrique Baca-García, Carmen Diaz-Sastre, Antonio Ceverino, Jeronimo Saiz-Ruiz, Francisco J. Diaz, and Jose de Leon (March/April 2003). "Association Between the Menses and Suicide Attempts: A Replication Study". Psychosomatic Medicine 65 (2): 237–44. doi:10.1097/01.PSY.0000058375.50240.F6. PMID 12651991. http://www.psychosomaticmedicine.org/cgi/content/full/65/2/237. Retrieved 2008-12-02. 
  34. ^ Maguire JL, Stell BM, Rafizadeh M, Mody I (June 2005). "Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety". Nat. Neurosci. 8 (6): 797–804. doi:10.1038/nn1469. PMID 15895085. 
  35. ^ Doufas AG, Mastorakos G (2000). "The hypothalamic-pituitary-thyroid axis and the female reproductive system". Annals of the New York Academy of Sciences 900: 65–76. PMID 10818393. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0077-8923&date=2000&volume=900&spage=65. 
  36. ^ Krejza J, Nowacka A, Szylak A, Bilello M, Melhem LY (July 2004). "Variability of thyroid blood flow Doppler parameters in healthy women". Ultrasound in medicine & biology 30 (7): 867–76. doi:10.1016/j.ultrasmedbio.2004.05.008. PMID 15313319. 
  37. ^ Stern K, McClintock MK (1998). "Regulation of ovulation by human pheromones". Nature 392 (6672): 177–9. doi:10.1038/32408. PMID 9515961. 
  38. ^ Adams, Cecil (2002-12-20). "Does menstrual synchrony really exist?". The Straight Dope. The Chicao Reader. http://www.straightdope.com/columns/021220.html. Retrieved 2007-01-10. 
  39. ^ Galan, Nicole (2008-04-16). "Oligoovulation". about.com. http://pcos.about.com/od/glossary/g/oligoovulation.htm. Retrieved 2008-10-12. 
  40. ^ Weschler (2002), p.107
  41. ^ Anovulation at eMedicine
  42. ^ a b Menstruation Disorders at eMedicine
  43. ^ a b Oriel KA, Schrager S (October 1999). "Abnormal uterine bleeding". American Family Physician 60 (5): 1371–80; discussion 1381–2. PMID 10524483. http://www.aafp.org/afp/991001ap/1371.html. Retrieved 2008-10-12. 
  44. ^ a b Trussell, James (2007). "Contraceptive Efficacy". in Hatcher, Robert A., et al.. Contraceptive Technology (19th rev. ed.). New York: Ardent Media. ISBN 0-9664902-0-7. 
  45. ^ a b Speroff, Leon; Darney, Philip D. (2005). "Oral Contraception". A Clinical Guide for Contraception (4th ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 21–138. ISBN 0-781-76488-2. 
  46. ^ a b Loose, Davis S.; Stancel, George M. (2006). "Estrogens and Progestins". in Brunton, Laurence L.; Lazo, John S.; Parker, Keith L. (eds.). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11th ed.). New York: McGraw-Hill. pp. 1541–71. ISBN 0-07-142280-3. 
  47. ^ a b Glasier, Anna (2006). "Contraception". in DeGroot, Leslie J.; Jameson, J. Larry (eds.). Endocrinology (5th ed.). Philadelphia: Elsevier Saunders. pp. 3000–1. ISBN 0721603769. 
  48. ^ McNeilly AS (2001). "Lactational control of reproduction". Reprod. Fertil. Dev. 13 (7-8): 583–90. doi:10.1071/RD01056. PMID 11999309. http://www.publish.csiro.au/journals/abstractHTML.cfm?J=RD&V=13&I=8&F=RD01056abs.XML. 
  49. ^ Stallings JF, Worthman CM, Panter-Brick C, Coates RJ (February 1996). "Prolactin response to suckling and maintenance of postpartum amenorrhea among intensively breastfeeding Nepali women". Endocr. Res. 22 (1): 1–28. PMID 8690004. 
  50. ^ "Breastfeeding: Does It Really Space Babies?". The Couple to Couple League International. Internet Archive. 2008-01-17. http://web.archive.org/web/20080117232155/http://www.ccli.org/nfp/ebf/spacebabies.php. Retrieved 2008-09-21. , which cites:
    Sheila K. and John F. Kippley (November-December 1972). "The relation between breastfeeding and amenorrhea". Journal of obstetric, gynecologic, and neonatal nursing 1 (4): 15–21. PMID 4485271. 
    Sheila Kippley (November-December 1986 and January-February 1987). "Breastfeeding survey results similar to 1971 study". The CCL News 13 (3): 10.  and 13(4): 5.
  51. ^ Cohen, Sari (February-March 2005). "Melatonin, menstruation, and the moon". Townsend Letter for Doctors and Patients. http://findarticles.com/p/articles/mi_m0ISW/is_259-260/ai_n10299307/pg_1. Retrieved 2008-09-21. 
    Knight, Chris; Camilla Power & Ian Watts (1995). "The Human Symbolic Revolution: A Darwinian Account" (PDF). Cambridge Archaeological Journal 5 (1): 75–114. doi:10.1017/S0959774300001190. http://www.radicalanthropologygroup.org/pub_knight_power_watts_big.pdf. Retrieved 2006-12-13. 
    Lacey, Louise (1975). Lunaception: a feminine odyssey into fertility and contraception. New York: Coward, McCann & Geoghegan. ISBN 0-698-10674-1. 
  52. ^ Singer, Katie. "Fertility Awareness, Food, and Night-Lighting". Wise Traditions in Food, Farming and the Healing Arts, Spring 2004. See section on Night-Lighting.
  53. ^ Harder, Ben (Week of August 28, 2004). "Bright nights kindle cancers in mice". Science News 166 (9): 141. 
  54. ^ Danilenko KV, Samoilova EA (2007). "Stimulatory effect of morning bright light on reproductive hormones and ovulation: results of a controlled crossover trial". PLoS clinical trials 2 (2): e7. doi:10.1371/journal.pctr.0020007. PMID 17290302. 
  55. ^ Shannon, Marilyn M. (2001). Fertility, cycles & nutrition : how your diet affects your menstrual cycles & fertility (3rd ed.). Cincinnati, Ohio: Couple to Couple League International. pp. 71–2. 
  56. ^ a b Knott, Cheryl (2003). "Orangutans: Reproduction and Life History". Gunung Palung Orangutan Project. Harvard University. http://www.fas.harvard.edu/~gporang/orangutans.html. Retrieved 2008-10-05. 
  57. ^ Lacreuse A, Chennareddi L, Gould KG, et al. (September 2008). "Menstrual cycles continue into advanced old age in the common chimpanzee (Pan troglodytes)". Biology of reproduction 79 (3): 407–12. doi:10.1095/biolreprod.108.068494. PMID 18495682. 
  58. ^ As cited by Adams, Cecil, "What's the link between the moon and menstruation?" (accessed 6 June 2006):
    Abell, George O.; Barry Singer (1983). Science and the Paranormal: Probing the Existence of the Supernatural. Scribner Book Company. ISBN 0-684-17820-6. 
  59. ^ Cutler WB (August 1980). "Lunar and menstrual phase locking". Am. J. Obstet. Gynecol. 137 (7): 834–9. PMID 7405975. 
  60. ^ Friedmann E (June 1981). "Menstrual and lunar cycles". Am. J. Obstet. Gynecol. 140 (3): 350. PMID 7246643. 
  61. ^ Law SP (1986). "The regulation of menstrual cycle and its relationship to the moon". Acta Obstet Gynecol Scand 65 (1): 45–8. PMID 3716780. 
  62. ^ Zimecki M (2006). "The lunar cycle: effects on human and animal behavior and physiology". Postepy Hig Med Dosw (Online) 60: 1–7. PMID 16407788. http://journals.indexcopernicus.com/fulltxt.php?ICID=442883. 
  63. ^ a b c "Estrus". Britannica Online. http://www.britannica.com/EBchecked/topic/193725/estrus. Retrieved 2008-10-05. 
  64. ^ Mikkelson, Barbara and David P. (2007-06-29). "Buried Pleasure". Snopes.com. http://www.snopes.com/critters/wild/pleasure.asp. Retrieved 2008-10-05. , which references:
    Diamond, Jared M. (1997). Why is sex fun?: the evolution of human sexuality. London: HarperCollins. ISBN 0-465-03127-7. 
  65. ^ Profet M (1993). "Menstruation as a defense against pathogens transported by sperm". Q Rev Biol 68 (3): 335–86. doi:10.1086/418170. PMID 8210311. 
  66. ^ "Canine False Pregnancy and Female Reproduction". Mar Vista Animal Medical Center. 2008-02-02. http://marvistavet.com/html/body_canine_false_pregnancy.html. Retrieved 2008-10-05. 
  67. ^ Studies that found women are more attractive to men when fertile:
    S.C. Roberts, J. Havlicek, J. Flegr, M. Hruskova, A.C. Little, B.C. Jones, D.I. Perrett and M. Petrie, M. (August 2004). "Female facial attractiveness increases during the fertile phase of the menstrual cycle". Proc.R.Soc.Lond.B (Suppl.) 271: S270–2. doi:10.1098/rsbl.2004.0174. 
    Geoffrey Miller, Joshua M. Tybur and Brent D. Jordan (June 2007). "Ovulatory cycle effects on tip earnings by lap dancers: economic evidence for human estrus?" (PDF). Evolution and Human Behavior 28 (6): 375. doi:10.1016/j.evolhumbehav.2007.06.002. http://www.unm.edu/~gfmiller/cycle_effects_on_tips.pdf. Retrieved 2008-01-21. 
  68. ^ Study that found male sexual behavior is not affected by female fertility:
    Susan B. Bullivant, Sarah A. Sellergren, Kathleen Stern, et al. (February 2004). "Women's sexual experience during the menstrual cycle: identification of the sexual phase by noninvasive measurement of luteinizing hormone". Journal of Sex Research 41 (1): 82–93. PMID 15216427. http://www.findarticles.com/p/articles/mi_m2372/is_1_41/ai_n6032944. 
  69. ^ Lanting, Frans; Waal, F. B. M. de (1997). Bonobo: the forgotten ape. Berkeley: University of California Press. pp. 107. ISBN 0-520-20535-9. http://www.serpentfd.org/a/dewall1997.html. Retrieved 2007-09-05. 
  70. ^ Stanford, Craig B. (March-April 2000). "The Brutal Ape vs. the Sexy Ape? The Make-Love-Not-War Ape". American Scientist 88 (2): 110. doi:10.1511/2000.2.110. 



 
 

 

Copyrights:

Sci-Tech Dictionary. McGraw-Hill Dictionary of Scientific and Technical Terms. Copyright © 2003, 1994, 1989, 1984, 1978, 1976, 1974 by McGraw-Hill Companies, Inc. All rights reserved.  Read more
World of the Body. The Oxford Companion to the Body. Copyright © 2001, 2003 by Oxford University Press. All rights reserved.  Read more
Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved.  Read more
Encyclopedia of Public Health. Encyclopedia of Public Health. Copyright © 2002 by The Gale Group, Inc. All rights reserved.  Read more
Sports Science and Medicine. The Oxford Dictionary of Sports Science & Medicine. Copyright © Michael Kent 1998, 2006, 2007. All rights reserved.  Read more
Health Dictionary. The New Dictionary of Cultural Literacy, Third Edition Edited by E.D. Hirsch, Jr., Joseph F. Kett, and James Trefil. Copyright © 2002 by Houghton Mifflin Company. Published by Houghton Mifflin. All rights reserved.  Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Menstrual cycle" Read more